AFC
ABVX

Ares Financial Consulting’s Abivax ABVX Stock Holding History

Ares Financial Consulting’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800 Buy
+6
New +$679 ﹤0.01% 1037

Other funds holding ABVX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Ares Financial Consulting's ABVX Position: Q2 2026 in Review

Ares Financial Consulting opened a new position in Abivax (ABVX) in Q2 2026: 6 shares worth $800. The stake represents ﹤0.01% of the portfolio and ranks #1037 among its holdings.

85 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Ares Financial Consulting held 6 shares of Abivax worth $800 as of Q2 2026.
  • Abivax was a new Ares Financial Consulting position in Q2 2026.
  • Abivax made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #1037 holding.
  • 85 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.